This content is from: Premium
RA Capital’s New VC Fund
The life sciences specialist is the latest hedge fund firm to raise additional capital to invest in private companies.
The most active life sciences hedge fund firm in the private markets has launched its third venture capital fund.RA Capital raised $880 million for RA Capital Nexus Fund III, which was “significantly oversubscribed,” according to a firm announcement. It brought in capital from existing and new investors, including a group of
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.